The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
暂无分享,去创建一个
C. Loge | A Novák | C de la Loge | L Abetz | E A van der Meulen | A. Novák | L. Abetz | C. de la Loge | E. van der Meulen | E. A. V. D. Meulen
[1] C. Egarter,et al. Low dose oral contraceptives and quality of life. , 1999, Contraception.
[2] D. Apter,et al. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. , 2001, Human reproduction.
[3] P. D. De Silva,et al. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives. , 1993, Contraception.
[4] J. Foidart,et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[5] H. Rekers. Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and Desogestrel , 1988, Acta obstetricia et gynecologica Scandinavica.
[6] J. Hanker,et al. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles , 1997 .
[7] M. Tuppurainen,et al. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. , 2002, American journal of obstetrics and gynecology.
[8] C. Timmer,et al. Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring , 2000, Clinical pharmacokinetics.
[9] D. Apter,et al. Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.
[10] C. Gerlinger,et al. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisterone , 2001 .
[11] J. Ranstam,et al. Oral contraceptive use among young women in southern Sweden. , 1993, Journal of epidemiology and community health.
[12] C. Gerlinger,et al. Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel , 2001 .
[13] T. Eskes,et al. Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[14] Caroline Bird,et al. What Women Want , 1979 .
[15] D. Shoupe. Multicenter Randomized Comparative Trial of Two Low‐Dose Triphasic Combined Oral Contraceptives Containing Desogestrel or Norethindrone , 1994, Obstetrics and Gynecology.
[16] B. Oddens,et al. The dynamics of oral contraceptive use in the Netherlands 1990–1993 , 1994, Advances in contraception : the official journal of the Society for the Advancement of Contraception.
[17] J. Rosenfeld,et al. Women's satisfaction with birth control. , 1993, The Journal of family practice.
[18] B J Oddens,et al. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. , 1999, Contraception.
[19] M. Rosenberg,et al. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. , 1995, Contraception.
[20] A. Kaunitz. Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial. , 2000, Contraception.